MS-681a, b, c and d are new inhibitors of myosin light chain kinase produced by Myrothecium sp. They are novel octapeptides containing a-alkyl-a-amino acids and a polyamine moiety. The structures were determined by NMRand FAB-MS/MS spectral analyses of the intact peptides.
MS-681a, b, c and d, New Inhibitors of Myosin Light Chain Kinase from Myrothecium sp. II. Physico-chemical Properties and Structure Elucidation
2-amino-3-phenylpropane unit (APP) was clarified by data of the WHCOSY, HSQC and HMBCexperiments in DMSO-d6 (Fig. 2a) . The connectivity of a spermidine unit was not observed in .The connectivities of the aminoacid residues were established from the 1H-13C correlations between the amide protons and the amide carbonyls and the NOEsbetween the amide protons and the a-protons. The structure of the TV-terminus was elucidated to be an acetyl phenylalanine by the 1H-13C correlation between the acetyl carbonyl group (3 170.2) and the amide proton (3 8.23) of Phe (1) . On the other hand, the 1H-13C correlation between the carbonyl group (5 172.3) of the C-terminal Iva (8) and the amide proton (3 6.93) ofAPP indicated that the C-terminus was linked by the Phe residue with the reduced peptide bond. The structure of the C-terminal polyamine moiety was confirmed by NMRexperiments in CD3ODas shown in Fig. 2b . The connectivity ofAPP and spermidine was assigned by the chemical shift of the methylene (3 48.0), which was directly bound to the terminal amino group of spermidine. Thus, the Cterminus was established as summarized in Fig. 2 . The sequence of 2 was confirmed by a positive ion
FAB-MS/MS of its gw<zs7-molecular ion (m/z 1111 (M+H)+).
The fragmentation pattern provided full evidence of the sequence of the amino acids and the f Present address : Drug Discovery Research Laboratories, Pharmaceutical Research Institute, KyowaHakko Kogyo Co., Ltd., 1 188 Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka-ken 41 1, Japan C-terminal polyamine moiety and was in agreement with shown in Fig. 3 . the results of the NMRexperiments (Fig. 3) . Thus, the The structures of 1, 3 and 4 were elucidated by cornstructure of the major component 2 was determined as parison with 2. The molecular formulae of 1, 3 and 4 Amino acid analysis of the hydrolysate and XHNMR and 13C NMRspectra of 1 were very similar to those of 2 expect for the presence of tryptophan (Trp) instead of Phe. The sequence of 1 was determined by a positive ion FAB-MS/MSof its gwos7-molecular ion (m/z 1150 (M + H)+). The fragmentation pattern was similar to that of 2 and clarified the fact that the seventh residue DEC. 1997 corresponding to Phe of 2 was a Trp (data not shown). The structures of 3 and 4 were determined in a same manner as described above and elucidated as shown in Fig. 1 . XHNMRdata of 1, 3 and 4 are summarized in Table 3 .
The presence of minor components in each crude samples of 1, 2, 3 and 41} was indicated in the FAB-MS by the ions observed at molecular weight 12 mass units higher than the molecular ions of 1, 2, 3 and 4,
respectively. The molecular formulae of the minor com-VOL.50
NO. 12 THE JOURNAL OF ANTIBIOTICS Table 3 . *H NMR data of MS-681a (1), b (2), c (3) and d (4) in CD3OD (400MHz).
Phe (1) C-2 4.35 -4.52 (m)
Iva (5) C-5 0.85 (t)
Gly (6) C-2 3.89 (t), 3.72
Phe (7) or C-2 4.35 -4.52 (m).
aromatic protons ponents of1, 2, 3 and 4 were established as C62H91N13O9, C60H90N12O9, C63H93N13O9 and C61H92N12O9 based on HRFAB-MS, respectively.
The structures of the minor components were confirmed by FAB-MS/MS of each quasi-molecular ion.
The TV-terminal fragmentation pattern of the minor componentof 2 was similar to that of 2. On the other hand, all the C-terminal ions observed were higher than corresponding ions of 2 by 12 mass units. From these results, the aminoacid sequence of the minor component of 2 was consistent with that of 2 and the difference was determined to be the polyamine moiety. Ions at m/z 170 and 1054 were attributed to cleavages of the polyamine region and the C-terminal polyamine structure of the minor componentof 2 was suggested to be as shownin Each fragmentation pattern of the minor components of 1, 3 and 4 was similar to that of the minor component Similarly, the stereochemistry ofIva of 1 and 3 was assigned as shown in Fig. 1 , and was supported by the fact that XHNMRdata of 1 and 3 were almost identical to those of 2 and 4 expect for the seventh residues, respectively. The absolute configurations of the tertiary carbons on the polyamine moieties of 1, 2, 3 and 4 were determined by comparison of HPLCretention times on a chiral column of tetratrifluoroacetate derivatives of 6 obtained from the acid hydrolysates of 1, 2, 3 and 4, with those of synthetic compounds (2'S> and {2'RS)-6. Condensation of a protected spermidine 73) with Boc-L-Phe afforded the amide (2'S)-8.
Reduction of the amide group of (2'5>8 afforded the protected (2'S)-6; which was deprotected to give (2'S)-6 (Scheme 1). By a similar procedure, (2'RS)-6 was prepared from Boc-Z>L-Phe. All the HPLCretention times of the tetratrifluoroacetates of 6 obtained from 1, 2, 3 and 4 were identical with that of (2'S)-6.
Consequently, the absolute configurations of the polyamine moieties of 1, 2, 3 and 4
were determined to be all S.
Conclusion
The structures of 1, 2, 3 and 4 were elucidated, including the absolute configurations of the amino acids and the polyamine moieties. These compoundsare unique octapeptides including an acetyl iV-terminus, a high amount of a-alkyl-a-amino acids, containing Aib and both enantiomers ofIva, and a C-terminal polyamine moiety. Related peptides containing a high amount of a-alkyla-amino acids such as Iva and Aib are the well-known peptaibol antibiotics4).
However, significant differences reside in the C-terminus of the MS-681 compounds, which have the polyamine residues instead of 1,2-aminoalcohol residues such as leucinol5) and phenylalaninol6) for the peptaibols. Analysis of the Amino Acids A solution of the MS-681 compounds (0.5mg) in 6n HC1 solution (1 ml) was heated at 110°C for 24 hours or 1 week in a vacuum-sealed tube. The hydrolysates were concentrated to residues in vacuo and dissolved in 0.02 n HC1solution and the solution was analyzed with the amino acid analyzer. 1 and 3 containing Trp were also hydrolyzed for 24 hours in the presence of 2-mercaptoethanesulfonic acid. The hydrolysates of 2 and 4 were subjected to preparative HPLCto give 5, which were hydrolyzed as described above.
5: FAB-MS m/z 525 (M+H)+; HPLC retention time DEC. 1997 7.1 minutes.
In order to determine the stereochemistry of amino acids, the hydrolytic residues of the MS-681 compounds (0.1 mg) and 5 and authentic amino acids (2mg) were derivatized to give the jV-trifluoroacetyl/rc-propyl esters in the reported manner2). The derivatives were analyzed by the GC spectrometer. The retention times of the authentic amino acids were 8.92 (Aib), 9.73 (£>-Iva), 9.84 Synthesis of A^-(2-Amino-3-phenylpropyl)spermidine
0.29ml, 1.06mmol) in DMF(5ml) and triethylamine (0.19ml, 1.35mmol) were added at 0°C. After stirring for 21 hours at the same temperature, the reaction mixture was mixed with a 1 n HC1solution and extracted with EtOAc. The organic layer was washed, dried and concentrated to give a crude product, which was chro- , 2975 , 2931 , 1695 , 1525 , 1365 , 1251 , 1170 XH NMR (100MHz, CDC13) 5 7.23 (5H, m), 5.27 (1H, m), 4.82 (1H, m), 4.35 (1H, m) (2/S)-7V 1 -(2-Amino-3-phenylpropyl)spermidine ((2/5' )-
borane-THF complex (1.0m solution in THF, 2.32ml, 2.32mmol) was added dropwise at -12°C. After stirring for 24 hours at room temperature, the reaction mixture was quenched with MeOH. After stirring for 17 hours, the reaction mixture was concentrated, diluted with water and adjusted to pH 3 with 1 n HC1solution. The aqueous layer was extracted with EtOAc and the organic layer dried and concentrated to give a crude product, which was chromatographed To a solution of (2'S)-7V4,7V8-bis(ter/-butoxycarbonyl)-A^1-{A^-(^r/-butoxycarbonyl)-2-amino-3-phenylpropyljspermidine (HOmg, 0.19mmol) in CH2C12 (6 ml), triftuoroacetic acid (6ml) was added at 0°C. After stirring for 30 minutes at room temperature, the reaction mixture was concentrated and washedwith n-hexane. In a similar mannerto that described for the preparation of (2'S)-8, compound 7 (1.60g, 4.63 mmol) was treated with A^-(^r?-butoxycarbonyl)-DL-phenylalanine (1.17g, 4.41 mmol), DPPA (1.18ml, 5.46mmol) (2/JR5')-A^1-(2-Amino-3-phenylpropyl)spermidine (2) (3) (4) (5) (6) In a similar manner to that described for the preparation of (2'S)-6, compound (2'RSyS (2.30g, 3.88 mmol) was treated with borane-THF complex (1.0m solution in THF, 7.76ml, 7.76mmol) to (2'RS)-N*,N8-bis(^r/-butoxycarbonyl)-A^1 -{7V-(^r/-butoxycarbonyl)-2-amino-3-phenylpropyl}spermidine, which was deprotected with trifluoroacetic acid (24 ml) to afford (2' RS)-6
as an oil (158mg, 16% from (2'RS)- Analysis of jV1-(2-Amino-3-phenylpropyl)spermidine (6) In order to determine the absolute configurations of 6 obtained from 1, 2, 3 and 4, the synthetic (2'S)-and (2'RS)-6 were derivatized to give the tetratrifluoroacetates. Each solution of synthetic (2'S)-and (TRS)-6 (1 mg) in trifluoroacetic anhydride (0.05 ml) and CH2C12 (0.2ml) was heated at 100°C for 1 hour in a sealed tube. Thereaction mixture wasconcentrated to give a crude product, which was purified by preparative TLC with CHCl3 -MeOH(10 : 1) to afford tetratrifluoroacetate. The derivatives and those of 1, 2, 3 and 4 were analyzed by HPLC.The retention times of tetratrifluoroacetates were 29.0 (R) and 31,5 minutes (5).
Tetratrifluoroacetate of (2'RS)-6; FAB-MSm/z 663 
